Synthetic immunotherapy induces HIV virus specific Th1 cytotoxic response and death of an HIV-1 infected human cell line through classic complement activation

BACKGROUND: This manuscript describes the development of a novel synthetic immunotherapy (HIV-v) composed of four multi-epitope polypeptides targeting conserved regions in the Nef, Rev, Vif and Vpr viral proteins. Immunogenicity and cytotoxicity of HIV-v are discussed. METHODS: Short conserved T-cel...

Descripción completa

Detalles Bibliográficos
Autores principales: Pleguezuelos, Olga, Stoloff, Gregory A, Caparrós-Wanderley, Wilson
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2013
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3626621/
https://www.ncbi.nlm.nih.gov/pubmed/23557359
http://dx.doi.org/10.1186/1743-422X-10-107

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3626621/
https://www.ncbi.nlm.nih.gov/pubmed/23557359
http://dx.doi.org/10.1186/1743-422X-10-107

Ejemplares similares